181 related articles for article (PubMed ID: 17156135)
1. Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data.
Horwhat JD; Baroni D; Maydonovitch C; Osgard E; Ormseth E; Rueda-Pedraza E; Lee HJ; Hirota WK; Wong RK
Am J Gastroenterol; 2007 Mar; 102(3):497-506. PubMed ID: 17156135
[TBL] [Abstract][Full Text] [Related]
2. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
3. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
Loughney T; Maydonovitch CL; Wong RK
Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018
[TBL] [Abstract][Full Text] [Related]
4. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
Hirota WK; Loughney TM; Lazas DJ; Maydonovitch CL; Rholl V; Wong RK
Gastroenterology; 1999 Feb; 116(2):277-85. PubMed ID: 9922307
[TBL] [Abstract][Full Text] [Related]
5. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M
World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
[TBL] [Abstract][Full Text] [Related]
7. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
8. Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia.
Benipal P; Garewal HS; Sampliner RE; Martinez P; Hayden CW; Fass R
Am J Gastroenterol; 2001 Nov; 96(11):3084-8. PubMed ID: 11721753
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
Vieth M; Schubert B; Lang-Schwarz K; Stolte M
Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus.
Horwhat JD; Maydonovitch CL; Ramos F; Colina R; Gaertner E; Lee H; Wong RK
Am J Gastroenterol; 2008 Mar; 103(3):546-54. PubMed ID: 17970838
[TBL] [Abstract][Full Text] [Related]
11. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy.
Eloubeidi MA; Provenzale D
Am J Gastroenterol; 1999 Apr; 94(4):937-43. PubMed ID: 10201460
[TBL] [Abstract][Full Text] [Related]
12. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease.
Pfaffenbach B; Hullerum J; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G
Z Gastroenterol; 2000 Jul; 38(7):565-70. PubMed ID: 10965553
[TBL] [Abstract][Full Text] [Related]
13. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
[TBL] [Abstract][Full Text] [Related]
15. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and molecular analysis of high-grade dysplasia and early adenocarcinoma in short- versus long-segment Barrett esophagus.
Nobukawa B; Abraham SC; Gill J; Heitmiller RF; Wu TT
Hum Pathol; 2001 Apr; 32(4):447-54. PubMed ID: 11331963
[TBL] [Abstract][Full Text] [Related]
18. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
19. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
20. Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study.
Leodolter A; Nocon M; Vieth M; Lind T; Jaspersen D; Richter K; Willich S; Stolte M; Malfertheiner P; Labenz J
Scand J Gastroenterol; 2012 Dec; 47(12):1429-35. PubMed ID: 23110405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
